* USANA Health Sciences Inc USNA.N USNA.K is expected
to show
a fall in quarterly revenue when it reports results on February
6 for the period ending December 31 2023
* The Salt Lake City Utah-based company is expected to
report a
6.8% decrease in revenue to $212.399 million from $227.96
million a year ago, according to the mean estimate from 2
analysts, based on LSEG data.
* LSEG's mean analyst estimate for USANA Health Sciences
Inc is
for earnings of 52 cents per share.
* The one available analyst rating on the shares is
"hold".
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for USANA
Health
Sciences Inc is $60.50, above its last closing price
of $47.23.
This summary was machine generated February 2 at 22:35 GMT. All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)